Genomic alterations predict clinical response to systemic chemotherapy and immune checkpoint blockade in biliary tract cancer

医学 内科学 肿瘤科 免疫检查点 免疫疗法 胆道癌 癌症研究 化疗 无容量 免疫系统 阿替唑单抗 癌症 封锁 彭布罗利珠单抗
作者
Min Kim,Jung Hyun Yoon,Mi Jang,H.J. Kim,Young Nyun Park,Min Geol Lee,Ho Kyoung Hwang,Chang Moo Kang,Woonhyoung Lee,Byunghag Kang,H.C. Chung,Hoseung Choi
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:30
标识
DOI:10.1093/annonc/mdz247.008
摘要

Abstract Background Previous studies have identified several targetable oncogenic mutations in biliary tract cancer (BTC). However, reliable predictors of clinical response to therapeutic agents have not been established. This study aimed to identify predictors of clinical response to chemotherapy and immune checkpoint blockade in advanced BTC patients. Methods Genomic alterations in 54 patients with recurrent or metastatic BTC were investigated by targeted deep-sequencing for 524 key cancer genes using pre-treatment tumor tissues. The predictive value of genomic alterations, including mutational signatures, on response to chemotherapy and anti-PD-1/PD-L1 therapy, was assessed. Results Frequently altered genes included TP53 (50.0%), NOTCH1 (31.5%), KRAS (24.1%), KMT2C (22.2%), BAP1 (22.2%), and ERBB2 (22.2%). BAP1 deletion and NOTCH1 mutation were associated with a favorable response to chemotherapy. The homologous recombination deficiency (HRD)-associated signature (signature 3) was significantly higher in the responding patients to chemotherapy and a positive correlation between the HRD-signature and BAP1 deletion was observed, suggesting that HRD caused by BAP1 deletion may contribute to a favorable response to chemotherapy. A high proportion of signature 12 was associated with favorable overall and progression-free survival after chemotherapy. Among 19 patients treated with anti-PD-1/PDL1 therapy, the mismatch repair (MMR) deficiency–associated signatures (signatures 6, 15, 20, and 26) were significantly higher in the responding patients. Conclusions This study identified several predictors on therapeutic response of advanced BTC. BAP1 deletion and NOTCH1 mutation were predictors of a favorable response to chemotherapy. Furthermore, the mutational signatures associated with HRD and MMR significantly correlated with the response to chemotherapy and anti-PD-1/PD-L1 therapy, respectively. Legal entity responsible for the study The authors. Funding National R&D Program for Cancer Control, Republic of Korea. Disclosure All authors have declared no conflicts of interest.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hhh发布了新的文献求助10
3秒前
我要看文献完成签到 ,获得积分10
3秒前
wdd完成签到 ,获得积分10
5秒前
李爱国应助开心薯片采纳,获得10
6秒前
7秒前
Z_yiming发布了新的文献求助10
7秒前
爱吃草莓和菠萝的吕可爱完成签到,获得积分10
9秒前
缥缈一刀发布了新的文献求助10
11秒前
小地蛋完成签到 ,获得积分10
12秒前
感谢大哥的帮助完成签到 ,获得积分10
12秒前
614521完成签到,获得积分10
14秒前
111完成签到,获得积分10
15秒前
王先生完成签到 ,获得积分10
15秒前
16秒前
殊荣完成签到,获得积分10
17秒前
JAMA兜里揣完成签到,获得积分10
17秒前
lalala完成签到 ,获得积分10
19秒前
王三歲完成签到,获得积分10
20秒前
你的背包完成签到,获得积分10
20秒前
Yang应助快乐枫采纳,获得10
21秒前
冷傲的如柏完成签到,获得积分10
22秒前
量子星尘发布了新的文献求助10
24秒前
Z_yiming完成签到,获得积分10
24秒前
刘雪晴完成签到 ,获得积分10
24秒前
CCL完成签到,获得积分10
25秒前
缥缈一刀完成签到,获得积分10
26秒前
yar应助坚强幼晴采纳,获得10
26秒前
茶茶完成签到,获得积分0
27秒前
斑点完成签到,获得积分10
27秒前
31秒前
鱼儿乐园完成签到 ,获得积分10
31秒前
XF完成签到,获得积分20
32秒前
32秒前
木之木完成签到,获得积分0
32秒前
哈哈哈哈完成签到,获得积分10
32秒前
奋斗摩托完成签到,获得积分10
34秒前
CC完成签到,获得积分10
34秒前
桃子e完成签到 ,获得积分10
35秒前
zhaoli完成签到 ,获得积分10
36秒前
老唐发布了新的文献求助50
37秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029